当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析 - 现金流量表

济川药业

(600566)

  

流通市值:271.89亿  总市值:273.65亿
流通股本:9.16亿   总股本:9.22亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金7,238,609,644.785,384,117,803.083,426,353,538.3710,857,090,326.96
收到其他与经营活动有关的现金500,618,714.82436,202,691.18279,960,858.83348,879,081.54
经营活动现金流入的平衡项目0000
经营活动现金流入小计7,739,228,359.65,820,320,494.263,706,314,397.211,205,969,408.5
购买商品、接受劳务支付的现金1,279,131,092.69845,180,631.8414,733,867.511,306,098,753.54
支付给职工以及为职工支付的现金748,286,916.83543,538,914.67311,405,011.86868,293,968.94
支付的各项税费1,101,814,341.1813,472,258.67506,019,494.241,649,967,405.33
支付其他与经营活动有关的现金2,870,483,310.642,050,852,523.041,135,353,470.523,917,650,644.86
经营活动现金流出的平衡项目0000
经营活动现金流出小计5,999,715,661.264,253,044,328.182,367,511,844.137,742,010,772.67
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,739,512,698.341,567,276,166.081,338,802,553.073,463,958,635.83
二、投资活动产生的现金流量:
收回投资收到的现金2,713,082,5002,443,082,5002,103,082,5004,653,315,385.94
取得投资收益收到的现金31,803,613.0416,869,339.7915,813,811.8182,122,255.04
处置固定资产、无形资产和其他长期资产收回的现金净额739,124.783,124.7-7,979,319.61
投资活动现金流入的平衡项目0000
投资活动现金流入小计2,745,625,237.742,460,034,964.492,118,896,311.814,743,416,960.59
购建固定资产、无形资产和其他长期资产支付的现金144,222,826.31107,635,215.9786,347,903.79301,644,623.9
投资支付的现金4,678,000,0004,408,000,000369,000,0004,836,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计4,822,222,826.314,515,635,215.97455,347,903.795,137,644,623.9
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-2,076,597,588.57-2,055,600,251.481,663,548,408.02-394,227,663.31
三、筹资活动产生的现金流量:
吸收投资收到的现金14,305,47814,305,478-14,207,600
取得借款收到的现金1,145,480,456.41773,509,834.94667,379,039.431,095,433,917.49
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,159,785,934.41787,815,312.94667,379,039.431,109,641,517.49
偿还债务支付的现金803,513,258.78351,356,307.08-400,000,000
分配股利、利润或偿付利息支付的现金1,211,308,339.481,199,264,214.268,343,069.44823,189,505.03
支付其他与筹资活动有关的现金22,798,939.1610,539,877.17,290,061.7837,141,021.79
筹资活动现金流出平衡项目0000
筹资活动现金流出小计2,037,620,537.421,561,160,398.4415,633,131.221,260,330,526.82
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-877,834,603.01-773,345,085.5651,745,908.21-150,689,009.33
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,214,919,493.24-1,261,669,170.93,654,096,869.32,919,041,963.19
加:期初现金及现金等价物余额7,737,982,810.087,737,982,810.087,737,982,810.084,818,940,846.89
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额6,523,063,316.846,476,313,639.1811,392,079,679.387,737,982,810.08
补充资料:
净利润-1,341,293,924.9-2,827,062,991.25
固定资产和投资性房地产折旧-139,600,700.37-276,957,972.05
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-139,600,700.37-276,957,972.05
无形资产摊销-12,417,910.21-24,241,125.35
长期待摊费用摊销-64,212.84-2,042,299.31
处置固定资产、无形资产和其他长期资产的损失-4,733.85--130,280.19
固定资产报废损失-97,662.23-1,089,302.99
公允价值变动损失--51,999,388.12--14,603,985.81
财务费用-15,879,320.48-17,583,918.49
投资损失--15,800,332--81,723,599.77
递延所得税-27,275,749.97-3,943,213.79
其中:递延所得税资产减少-13,282,651.11-16,713,849.7
递延所得税负债增加-13,993,098.86--12,770,635.91
存货的减少--207,560,524.16--98,601,442.43
经营性应收项目的减少-893,169,209.88-22,814,700.6
经营性应付项目的增加--542,073,785.89-476,510,317.56
其他-4,042,886.13-8,517,013.07
现金的期末余额-6,476,313,639.18-7,737,982,810.08
减:现金的期初余额-7,737,982,810.08-4,818,940,846.89
公告日期2024-10-262024-08-242024-04-202024-04-10
审计意见(境内)标准无保留意见
TOP↑